Functional Lung Imaging in Patients With Respiratory Compromise Undergoing Endobronchial Valve Placement
1 other identifier
observational
10
1 country
1
Brief Summary
Bronchoscopic lung volume reduction (BLVR) using endobronchial valves is effective in improving quality of life in patients suffering from emphysema. BLVR treatment in advanced emphysema requires targeted segmental or sub-segmental placement of endobronchial valves (EBV) to achieve total lobar occlusion to induce effective lobar volume reduction. BLVR procedure success rate declines in patients with incomplete lobar fissure integrity due to the potential for collateral ventilation to circumvent EBV lobar occlusion. Current methods that assess lobar collateral ventilation as a correlate of fissure integrity are imperfect, resulting in a significant percentage of patients having equivocal assessment, leading to suboptimal selection of patients and potential for inappropriate selection of patients for BLVR. Additionally, methods used to select the target lobe for EBV placement predominately rely on the extent of emphysematous destruction. There is also a need to select based on the extent of physiological disturbance at the lobar level. Distribution of ventilation or regional ventilation heterogeneity may be associated with collateral ventilation. Therefore, in this study we wish to quantify lobar distribution of ventilation and ventilation heterogeneity in patients undergoing investigation for BLVR to determine the additive contribution of functional lung imaging for assessing lobar physiological derangement and suitability for EBV treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2021
CompletedFirst Posted
Study publicly available on registry
January 24, 2022
CompletedStudy Start
First participant enrolled
July 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedOctober 24, 2022
October 1, 2022
1.3 years
December 22, 2021
October 20, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The objective of the current investigation is to determine whether XV technology can assist in determining lobar selection, indicators of success, or response-related clinical outcomes with BLVR.
Functional lung imaging analysis in endobronchial valve placement
functional lung imaging and software analysis will be available after the procedure
Study Arms (1)
Functional lung imaging
Assess the applicability of XV ventilation distribution and heterogeneity for BLVR candidate screening compared to conventional tools of quantitative HRCT and ventilation perfusion scanning.
Interventions
X-ray Velocimetry (XV) technology images the motion of the lungs, determines airway volumes and measures regional lung ventilation during spontaneous breathing.
Eligibility Criteria
Patients with COPD undergoing bronchoscopic lung volume reduction
You may qualify if:
- Emphysema
- Undergoing evaluation and planned treatment with BLVR
- Adults, 40 years of age and older
- Consents to functional lung imaging evaluation
- Access to previous chest CT as part of the clinical workup for BLVR
You may not qualify if:
- Known contraindication to BLVR
- Currently receiving mechanical ventilation, intensive or other critical care
- Pregnant women
- Contraindication to ionizing radiation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Temple Universitylead
- Respiratory Compromise Institutecollaborator
Study Sites (1)
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gerard Criner, MD
Temple University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2021
First Posted
January 24, 2022
Study Start
July 5, 2022
Primary Completion
November 1, 2023
Study Completion
December 1, 2023
Last Updated
October 24, 2022
Record last verified: 2022-10